share_log

Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Decreases By 24.1%

kopsource ·  Jan 21, 2023 23:11

Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 28,700 shares, a decrease of 24.1% from the December 15th total of 37,800 shares. Based on an average trading volume of 32,200 shares, the days-to-cover ratio is presently 0.9 days.

Alpha Tau Medical Trading Up 8.5 %

Alpha Tau Medical stock traded up $0.03 during midday trading on Friday, hitting $0.43. The stock had a trading volume of 12,588 shares, compared to its average volume of 32,317. The firm's fifty day moving average is $0.29 and its two-hundred day moving average is $0.43. Alpha Tau Medical has a 52-week low of $0.18 and a 52-week high of $1.06.

Get Alpha Tau Medical alerts:

Institutional Investors Weigh In On Alpha Tau Medical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DRTSW. Goldman Sachs Group Inc. purchased a new stake in Alpha Tau Medical in the 1st quarter worth approximately $42,000. Chicago Partners Investment Group LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $55,000. Jane Street Group LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $64,000. Whitebox Advisors LLC bought a new position in Alpha Tau Medical in the 3rd quarter worth approximately $65,000. Finally, Walleye Trading LLC bought a new position in Alpha Tau Medical in the 1st quarter worth approximately $65,000.

About Alpha Tau Medical

(Get Rating)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.

See Also

  • Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
  • MarketBeat Week in Review – 1/16 – 1/20
  • Does Old Dominion Show That Trucking Is Hitting The Brakes?
  • Nordstrom Puts Fear Of Markdowns Into Retail Sector
  • Exxon Mobil Stock: Within Striking Distance Of Buy Point
  • High-Dividend-Yielding BHP Sees China Driving '23 Growth

Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment